Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

36.24 USD -1.07 (-2.87%)
Official Closing Price Updated: 7:48 PM EST, Jan 27, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Thinking about trading options or stock in Pfizer, Ligand Pharmaceuticals, Capital One Financial, GSX Techedu, or National Beverage?
InvestorsObserver issues critical PriceWatch Alerts for PFE, LGND, COF, GSX, and FIZZ. 
From PR Newswire
Scientists Still Relentlessly Working to Develop Newest, More Advanced Antiviral Therapies for COVID-19 Treatments
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Scientists Still Relentlessly Working to Develop Newest, More Advanced Antiviral Therapies for COVID-19 Treatments
Financialnewsmedia.com News Commentary 
From PR Newswire
Pfizer Shares Co-Primary Endpoint Results from Post-Marketing Required Safety Study of XELJANZ® (tofacitinib) in Subjects with Rheumatoid Arthritis (RA)
Pfizer Inc. (NYSE: PFE) announced today co-primary endpoint results from a recently completed post-marketing required safety study, ORAL Surveillance (A3921133; NCT02092467). The primary objective of... 
From Business Wire News Releases
Myovant Sciences and Pfizer Announce Positive One-Year Data from Phase 3 SPIRIT Extension Study of Once-Daily Relugolix Combination Therapy in Women with Endometriosis
From GlobeNewswire News Releases
Consumers Continue Flocking to Immune-Boosting Supplements as Health Crisis Rage On
The health crisis has completely changed life as we know it and caused a significant shift in consumer demand for immune-boosting products, vitamins, and supplements. Now, due to growing awareness... 
From PR Newswire
Consumers Continue Flocking to Immune-Boosting Supplements as Health Crisis Rage On
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
European Commission Approves BAVENCIO® (avelumab) for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
- BAVENCIO maintenance treatment significantly extended median overall survival versus standard of care in the Phase III JAVELIN Bladder 100 study 
From PR Newswire
Pfizer and BioNTech Reach Agreement with COVAX for Advance Purchase of Vaccine to Help Combat COVID-19
Pfizer and BioNTech SE today announced an advance purchase agreement with COVAX for up to 40 million doses of the Pfizer-BioNTech COVID-19 Vaccine. The doses will be delivered throughout 2021. 
From Business Wire News Releases
Thinking about trading options or stock in Intel Corp, Moderna, Microsoft, Pfizer, or Nvidia?
InvestorsObserver issues critical PriceWatch Alerts for INTC, MRNA, MSFT, PFE, and NVDA. 
From PR Newswire
ViiV Healthcare announces FDA approval of Cabenuva (cabotegravir, rilpivirine), the first and only complete long-acting regimen for HIV treatment
ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer Inc. and Shionogi Limited as shareholders, today announced that the US Food and Drug... 
From Business Wire News Releases
Pfizer and BioNTech Publish Results of Study Showing COVID-19 Vaccine Elicits Antibodies that Neutralize Pseudovirus Bearing the SARS-CoV-2 U.K. Strain Spike Protein in Cell Culture
From GlobeNewswire News Releases
Thinking about trading options or stock in Axon Enterprise, Tilray, Pfizer, Crispr Therapeutics, or General Motors?
InvestorsObserver issues critical PriceWatch Alerts for AAXN, TLRY, PFE, CRSP, and GM. 
From PR Newswire
Pfizer’s XALKORI® (crizotinib) Approved by FDA for ALK-positive Anaplastic Large Cell Lymphoma in Children and Young Adults
Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for XALKORI® (crizotinib) for the treatment of pediatric... 
From Business Wire News Releases
Thinking about trading options or stock in Plug Power, Pfizer, Carnival Corp, American Airlines, or Bilibili?
InvestorsObserver issues critical PriceWatch Alerts for PLUG, PFE, CCL, AAL, and BILI. 
From PR Newswire
Researchers Seek to Better Understand Psychedelics' Role in New Therapies
FinancialBuzz.com News Commentary 
From PR Newswire
Vedanta Biosciences Announces $25 Million Investment from Pfizer Inc.
Vedanta announces $25 million investment from Pfizer Inc. as part of the Pfizer Breakthrough Growth Initiative. 
From Business Wire News Releases
PureTech Founded Entity Vedanta Biosciences Announces $25 Million Investment from Pfizer Inc.
PureTech Founded Entity Vedanta announces $25 million investment from Pfizer Inc. as part of the Pfizer Breakthrough Growth Initiative. 
From Business Wire News Releases
Pfizer Invests $120 Million in Biotechnology Innovation Through the Pfizer Breakthrough Growth Initiative
Pfizer Inc. (NYSE: PFE) today announced that, during the second half of 2020, it invested a total of $120 million in four clinical-stage biotech companies as part of the Pfizer Breakthrough Growth... 
From Business Wire News Releases
Moderna Provides Business Update and Announces Three New Development Programs in Infectious Disease Vaccines
Moderna Provides Business Update and Announces Three New Development Programs in Infectious Disease Vaccines 
From Business Wire News Releases
CureDuchenne Congratulates Pfizer on Dosing First Patient in Phase III Clinical Trial for Duchenne Muscular Dystrophy
CureDuchenne, a leading global nonprofit dedicated to finding and funding a cure for Duchenne muscular dystrophy (DMD), celebrates Pfizer Inc’s (NYSE: PFE) announcement surrounding the first dosing of... 
From Business Wire News Releases
Thinking about trading options or stock in Nio, Plug Power, Pfizer, Sorrento Therapeutics, or BioNTech?
InvestorsObserver issues critical PriceWatch Alerts for NIO, PLUG, PFE, SRNE, and BNTX. 
From PR Newswire
An In Vitro Study Shows Pfizer-BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with a Mutation Associated with Rapid Transmission
From GlobeNewswire News Releases
Thinking about trading options or stock in Pfizer, Tesla, General Motors, JPMorgan Chase, or UnitedHealth Group?
InvestorsObserver issues critical PriceWatch Alerts for PFE, TSLA, GM, JPM, and UNH. 
From PR Newswire
Corinne Le Goff, Pharm.D. Will Join Moderna as Chief Commercial Officer on January 19
Corinne Le Goff, Pharm.D. will join Moderna as Chief Commercial Officer on January 19. 
From Business Wire News Releases
Pfizer Doses First Participant in Phase 3 Study for Duchenne Muscular Dystrophy Investigational Gene Therapy
Pfizer Inc. (NYSE: PFE) today announced that the first participant has been dosed in the Phase 3 CIFFREO study, which will evaluate the efficacy and safety of investigational gene therapy candidate... 
From Business Wire News Releases
ImaginAb Announces License and Supply Agreement with Pfizer for CD8 ImmunoPET Technology
ImaginAb Inc., a leading global provider of immuno-oncology imaging agents, today announced it has signed a new multi-year, non-exclusive license with Pfizer Inc. (NYSE: PFE) to supply 89Zr CD8... 
From PR Newswire
Thinking about buying stock in Citigroup, Pfizer, CleanSpark, FuelCell Energy, or BP?
InvestorsObserver issues critical PriceWatch Alerts for C, PFE, CLSK, FCEL, and BP. 
From PR Newswire
Dewpoint Announces Collaboration with Pfizer to Develop Potential Therapies for a Rare Form of Muscular Dystrophy
Dewpoint Therapeutics, the biomolecular condensates company, today announced a new research collaboration with Pfizer (NYSE: PFE) for the development of potential therapeutics for the treatment of... 
From PR Newswire
Pfizer Invites Public to Listen to Two Webcasts of Pfizer Discussions at Healthcare Conference
Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to two webcasts of discussions with Pfizer leadership at the 39th Annual J.P. Morgan Healthcare Conference to be held... 
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.